HNGF6A TFA is a humanin analogue. HNGF6A TFA increases glucose-stimulated insulin secretion and glucose metabolism, and has the potential for diabetes research. HNGF6A TFA inhibits of ROS production during oxidative stress. HNGF6A TFA can prevent endothelial dysfunction and atherosclerosis in vivo[1][2].
Molecular Weight:
2581.11 (free acid)
Formula:
C112H198N34O31S2.xC2HF3O2
Target:
Reactive Oxygen Species (ROS)
Application Notes:
MCE Product type: Peptides
* VAT and and shipping costs not included. Errors and price changes excepted